RE:RE:RE:RE:RE:RE:RE:JV with Merck's Keyteuda a bad idea...I would give them a break on the initial dosing, this was new technology,and as far as the frequent PPs we will be very happy in the long run im sure, but i definitely feel we need grants or a JV and i would bet to say something is in the works, where they have some type of non disclosure in place until agreed upon. We have waited this long, im sure they straightened out what the FDA was looking for, now is the quiet before the storm. i predict wiith 2 months we are above $2. Im staying long and have been adding , averaged way down now